MedChemComm
 | |
| Discipline | Chemistry, Medicine |
|---|---|
| Language | English |
| Edited by | Anthony Wood, Greg Verdine |
| Publication details | |
| History | 2010-present |
| Publisher | Royal Society of Chemistry (United Kingdom) |
| Frequency | Monthly |
| hybrid | |
| Standard abbreviations | |
| ISO 4 | MedChemComm |
| Indexing | |
| ISSN | 2040-2503 (print) 2040-2511 (web) |
| LCCN | 2011243017 |
| OCLC no. | 663378788 |
| Links | |
MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry. It is published monthly by the Royal Society of Chemistry. Authors can elect to have accepted articles published as open access.[1]
The editors-in-chief of MedChemComm are Anthony Wood (Pfizer, UK) and Greg Verdine (Harvard University). MedChemComm is the official journal of the European Federation for Medicinal Chemistry (EFMC).
Subject coverage
MedChemComm publishes articles on all aspects of the medicinal chemistry including drug discovery, pharmacology and pharmaceutical chemistry.
Article types
MedChemComm publishes Concise Articles (original scientific work, 3-7 pages in length) and Reviews (critical analyses of specialist areas).[2]
References
- ^ http://www.rsc.org/Publishing/Journals/OpenScience/index.asp Retrieved 2011-04-07
- ^ http://www.rsc.org/publishing/journals/md/about.asp Retrieved 2011-04-07